Portfolio comparison
Immatics Biotechnologies vs Dexcom
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
Training Immune Cells to Fight Cancer Using Specific Markers
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
Company B
Dexcom
Patents indexed
3
Year range
2016 – 2022
Most recent
2022
How Glucose Sensors Check Their Own Reliability for Insulin Pumps
A Catheter That Measures Glucose While Delivering Medication
How a Sensor Checks Itself for Accuracy Using Other Body Data
Activity by Decade
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.